Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

Delayed Quote. Delayed  - 08/24 10:01:21 pm
7.47 USD   -2.35%
08/24 RITE AID : Eastpointe man shot by 91-year-old Detroiter is charged
08/24 ROBBERS TAKE PA : Police
08/24 RITE AID : to open Thursday in downtown Allentown
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Rite Aid 4Q Loss Narrows Amid Sales Growth, Tax Benefit

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/12/2012 | 07:27pm CEST

--Same-store sales improve for five straight quarters with rollout of loyalty program and renovated stores

--Rite Aid converted 280 stores into new wellness format in the latest quarter

--Loss was greater than analysts expected and new fiscal-year outlook is tempered

(Updates the second paragraph with the latest stock quote and analyst commentary in the eighth through 12th paragraphs.)

 
   By John Kell 
   Of  
 

Rite Aid Corp.'s (>> Rite Aid Corporation) fiscal fourth-quarter loss narrowed as the drug-store company benefited from an extra week of sales and a tax benefit in the latest period.

The chain's loss was greater than analysts expected and its view for the new fiscal year was tempered, though shares were flat at $1.70 in recent trading Thursday as the broader market rallied higher.

The No. 3 U.S. drug-store chain behind Walgreen Co. (WAG) and CVS Caremark Corp. (>> CVS Caremark Corporation) has posted losses since its 2007 acquisition of the Brooks and Eckerd chains that saddled it with debt just before consumers slashed spending. It has benefited from cutting costs and refinancing billions of dollars in debt, and the company has seen sales growth recently after a long stretch of declines.

Rite Aid's same-store sales have improved for the past five quarters as the company benefits from the rollout of a loyalty program and store renovations under a new format that expands clinical pharmacy services and offers more health and wellness products. Rite Aid converted 280 stores into the new wellness format during the latest quarter, and, while still early in that process, President and Chief Executive John Standley said the effort was helping bolster front-end sales.

Standley told analysts during the company's conference call that enrollment in the Wellness+ loyalty program, which was launched in April 2010, has reached 52 million members and with two years of membership activity the drug-store chain has enough history and data to monitor active members who have used their cards at least twice in the last 26 weeks.

The company's effort to offer more flu immunizations, meanwhile, resulted in the administration of nearly 1.5 million flu shots in the latest fiscal year, more than double the prior year's total. That improvement came amid a mild cold and flu season that hurt the latest quarterly results from CVS and Walgreen.

Standley also noted a marketing campaign helped court customers forced to shift their prescriptions away from Walgreen after that drug-store chain exited from pharmacy-benefit manager Express Scripts Holding Co.'s (ESRX) network following a contract dispute.

Analysts say increasingly contentious contract disputes between payers and providers, as well as reimbursement-rate pressures, would justify consolidation between the top three drug-store chains. Though some speculate Walgreen may look to acquire Rite Aid as a solution to the contract impasse with Express Scripts, others argue a new contract agreement could be reached by this summer.

Raymond James analyst John Ransom said the latest market speculation suggests Walgreen may be more inclined to settle with Express, which earlier this month completed its $29.1 billion acquisition of peer Medco Health Solutions. That would lessen some of the upside thesis to Rite Aid's shares.

Ransom said that even though Rite Aid's new management team "has worked wonders with a really tough hand to play," the company remains heavily leveraged with more than $6 billion in debt and very minimal free cash flow generation.

Imperial Capital analyst Mary Ross Gilbert said her firm has long seen Rite Aid as a longer-term acquisition target, though she notes management continues to improve the business from an operating standpoint. She touted the value of the company's Northeast and West Coast locations and said Rite Aid has kept capital expenditures at a fairly low level.

Ross Gilbert noted Rite Aid's execution of late has kept the business relatively stable and with financial markets in their favor, the company has the ability to refinance maturities as they come due.

For the quarter ended March 3, Rite Aid reported a loss of $161.3 million, or 18 cents a share, from a year-earlier loss of $205.7 million, or 24 cents a share. The latest period included $56.3 million in termination and impairment charges, along with a $24.2 million tax benefit, while the prior year included $154.1 million in charges and a small tax expense.

Analysts polled by Thomson Reuters most recently projected a loss of 14 cents.

Gross margin fell to 24.9% from 26.4%.

Rite Aid recently reported total drug-store sales of $7.12 billion, up 11% from a year earlier, mostly owing to an extra week of sales in the period. Same-store sales improved 3%, the drug-store chain's best showing in five years.

Looking to fiscal 2013, Standley said Rite Aid intends to remodel 500 stores into the wellness format. For the year, the company projected a per-share loss of 13 cents to 31 cents on revenue of $25.4 billion and $25.8 billion. Analysts polled by Thomson Reuters recently expected a loss of 25 cents and revenue of $25.74 billion. Rite Aid expects same-store sales growth of up to 1.5% over the just-completed fiscal year.

-By John Kell, Dow Jones Newswires; 212-416-2480; john.kell@dowjones.com

--Tess Stynes contributed to this article.

Stocks mentioned in the article : Rite Aid Corporation, CVS Caremark Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
08/24 RITE AID : Eastpointe man shot by 91-year-old Detroiter is charged
08/24 ROBBERS TAKE PAINKILLERS FROM LEBANO : Police
08/24 RITE AID : to open Thursday in downtown Allentown
08/23 RITE AID : RediClinic and Hackensack Meridian Health Form Joint Venture To Open ..
08/23 POLICE LOGS : Jaffrey - Aug. 23, 2016
08/21 RITE AID : Back-To-School Savings Will Fill Up Your Backpack
08/20 RITE AID : Clinical study to discover if supplement can prevent diabetes
08/19 Back to school preparation
08/18 RITE AID : Morgan County Restaurant Ratings
08/18 RITE AID : Stanford PD arrests woman for using counterfeit money
More news
Sector news : Retail - Drugs without Grocery
08/22DJSINOPHARM GROUP : 1st Half Net Profit CNY2.53 Billion, Up 32% on Year
08/17DJTarget Dims Outlook as Sales Struggle
08/09DJPatient Survey Company Press Ganey to Sell Itself to Swedish Firm EQT
08/09DJValeant Posts a Loss and Says It Will Retool
08/05DJAbbVie Sues Amgen Over Humira
More sector news : Retail - Drugs without Grocery
News from SeekingAlpha
08/22 Berkshire Boosts Apple Stake And Other Moves From Top Managers
08/19 Top Merger Stocks Held By Fund Managers (Mid-Q3 2016 Edition)
08/18 Activists Circling Bank Of America?
08/18 RITE AID : Hedge Funds Circle To Take Advantage Of The Arbitrage
08/17 Tracking David Einhorn's Portfolio - Q2 2016 Update
Advertisement
Financials ($)
Sales 2017 32 966 M
EBIT 2017 709 M
Net income 2017 151 M
Debt 2017 6 717 M
Yield 2017 -
P/E ratio 2017 46,34
P/E ratio 2018 29,96
EV / Sales 2017 0,44x
EV / Sales 2018 0,42x
Capitalization 7 836 M
More Financials
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 8,86 $
Spread / Average Target 19%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kenneth A. Martindale President & Chief Operating Officer
Darren W. Karst SEVP, Chief Financial & Administrative Officer
Steve Rempel Chief Information Officer & Senior Vice President
Joseph B. Anderson Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION-4.72%7 836
RAIA DROGASIL SA67.79%6 012
AIN HOLDINGS INC13.41%2 066
ORIOLA KD OYJ-2.31%871
AUSTRALIAN PHARMACEUTI..-0.78%709
ADCOCK INGRAM HOLDINGS..-6.14%572
More Results